We describe a unique case of adult T-cell leukemia/lymphoma (ATL). The patient had typical clinicohematological features as ATL, but showed a lack of antibody to human T-cell leukemia virus type-1 (HTLV-1) and was negative for HTLV-1 proviral DNA in the peripheral mononuclear cells by means of polymerase chain reaction. The phenotype of tumor cells revealed CD7+, CD5+, CD2+, CD3+, WT31-, TcR delta 1-, CD4-, CD8-, CD25-, and the karyotype showed a 5q-, t(12;18). HTLV-1 unrelated ATL is very rare, and the karyotype as in our case has not been reported previously.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/(sici)1096-8652(200005)64:1<64::aid-ajh11>3.0.co;2-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Southern African Origin of HTLV-1 in Romania.
PLoS Negl Trop Dis
August 2024
Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Paris, France.
In Europe, most HTLV-1-infected individuals originate from highly endemic regions such as West Indies, sub-Saharan Africa, and South America. The only genuine endemic region for HTLV-1 in Europe is Romania where ATL series have been reported among Romanian patients. Our objective is to better understand the origin of this endemic focus based on a study of the genetic diversity of HTLV-1 in Romanians.
View Article and Find Full Text PDFLarge-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic Paraplegias.
Neurol Genet
February 2024
From the Department of Neurology (N.T., J.Y., T.S., S.M., Y.Y.); Department of Rare Diseases Research (N.Y., N.A., S.A., J.Y., K. Takahashi, Y. Kunitomo, T.S., Y.Y.), Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki; Advanced Business Promotion Department (S.A.), Business Development Segment, LSI Medience Corporation, Tokyo; Department of Clinical Neuroscience and Therapeutics Hiroshima University Graduate School of Biomedical and Health Sciences (M.N.); Genome Medical Science Project (Y. Kawai, Y.O., K. Tokunaga), National Center for Global Health and Medicine, Tokyo; and Center for Genomic Medicine (F.M.), Kyoto University Graduate School of Medicine, Japan.
Objectives: Distinguishing human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy from hereditary spastic paraplegia in patients infected with HTLV-1 is challenging due to overlapping clinical symptoms. The aim of this study was to explore the possibility that hereditary spastic paraplegia is inherently present in patients diagnosed with HTLV-1-associated myelopathy.
Methods: We performed whole-genome sequencing on 315 unrelated patients registered in the HTLV-1-Associated Myelopathy patient registry "HAM-net," from 2013 to 2022 in Japan.
Evaluating the diagnostic accuracy of TpN17 and TmpA recombinant proteins in syphilis detection: a phase II study.
Front Microbiol
February 2024
Advanced Public Health Laboratory, Gonçalo Moniz Institute (IGM) Foundation Oswaldo Cruz (Fiocruz-BA), Salvador, Brazil.
Syphilis is a sexually transmitted infection (STI) caused by the spiral bacterium . Diagnosis is based on epidemiology, clinical and serology, but serodiagnosis is challenging because distinct clinical forms of the infection may influence serological performance. Several recombinant -proteins have already been tested for syphilis diagnosis and they are critical to achieve high accuracy in serological testing.
View Article and Find Full Text PDFPutative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population.
Sci Rep
May 2023
Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil.
Article Synopsis
- About ten million people globally are infected with HTLV-1, with 1-4% developing a severe disease called HAM/TSP, which can lead to spinal cord degeneration and death.
- The study examined HLA alleles in 375 HTLV-1-infected individuals in Brazil to determine their influence on HAM/TSP risk, clinical progression, and death outcomes.
- Key findings revealed that specific HLA alleles, such as HLA-A*68, were linked to increased HAM/TSP risk, while others like HLA-A*33 offered protection; certain alleles also correlated with higher proviral load (PVL) and worse outcomes.
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
Clin Infect Dis
September 2023
Harvard Medical School, Boston, Massachusetts, USA.
Background: Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurological condition characterized by progressive myelopathic symptoms including spasticity, pain, weakness, and urinary symptoms, without proven treatments. Mogamulizumab (MOG) is a monoclonal antibody that binds CCR4 and leads to the clearance of HTLV-1-infected CCR4+ cells. A phase 1-2a study in Japan evaluated MOG for the treatment of HAM/TSP and reported decreases in HTLV-1 proviral load and neuroinflammatory markers, with clinical improvement in some participants.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!